The Bottom Line: Treatment of depression during pregnancy requires harm-benefit analysis of the risk of pharmacological agents to the fetus versus the maternal risk of failing to eat or take care of herself, failing to seek neonatal care, suicidal thoughts, or thoughts of killing the fetus. For up-to-date information regarding antidepressant use in pregnancy, click here.>
1. Szigethy EM and Wisner KL. Psychopharmacological treatment of mood and anxiety disorder during pregnancy. In: Mood disorders in women. Eds: Steiner M, Yonkers KA and Eriksson E. London: Sage Publications, 1994.